InsidersTradesSigma
케이엠제약: management transactions · South Korea · DART (FSS)
DART:company-1d9efbKR·DART (FSS)Mcap 15.0Bn€
Browse the full management transaction log of 케이엠제약, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Market capitalisation: €15bn. The latest transaction was reported on 9 April 2026 (Purchase). Among the most active insiders: 강일모. The full history is openly available.
5
Insider Decl.
0
Thresholds
€109,057
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
517.00 €
Income statement
Revenue15.99 Bn€
Gross profit3.84 Bn€24% margin
Net income−3.97 Bn€-24.8% margin
Balance sheet & cash
Market cap15.00 Bn€
Total debt15.80 Bn€
Free Cash Flow−2.01 Bn€
Last declaration on 9 April 2026
Declarations5 total
Executives●Purchase2DART
€7,1115,994 shares
KRX
DART:20260313000300·
Ideal exit: 8 Dec 2026 (T+270)
5 of 5 declarations